- Home
- XPOF vs ALT Comparison
XPOF vs ALT Comparison
Compare XPOF & ALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XPOF
- ALT
- Stock Information
- Founded
- XPOF 2017
- ALT 1997
- Country
- XPOF United States
- ALT United States
- Employees
- XPOF N/A
- ALT N/A
- Industry
- XPOF Services-Misc. Amusement & Recreation
- ALT Biotechnology: Pharmaceutical Preparations
- Sector
- XPOF Consumer Discretionary
- ALT Health Care
- Exchange
- XPOF Nasdaq
- ALT Nasdaq
- Market Cap
- XPOF 302.9M
- ALT 348.6M
- IPO Year
- XPOF 2021
- ALT N/A
- Fundamental
- Price
- XPOF $5.83
- ALT $4.66
- Analyst Decision
- XPOF Buy
- ALT Strong Buy
- Analyst Count
- XPOF 8
- ALT 7
- Target Price
- XPOF $12.19
- ALT $16.33
- AVG Volume (30 Days)
- XPOF 726.6K
- ALT 3.0M
- Earning Date
- XPOF 11-06-2025
- ALT 11-06-2025
- Dividend Yield
- XPOF N/A
- ALT N/A
- EPS Growth
- XPOF N/A
- ALT N/A
- EPS
- XPOF N/A
- ALT N/A
- Revenue
- XPOF $315,135,000.00
- ALT $20,000.00
- Revenue This Year
- XPOF N/A
- ALT N/A
- Revenue Next Year
- XPOF $2.45
- ALT N/A
- P/E Ratio
- XPOF N/A
- ALT N/A
- Revenue Growth
- XPOF N/A
- ALT N/A
- 52 Week Low
- XPOF $5.58
- ALT $2.90
- 52 Week High
- XPOF $18.87
- ALT $10.88
- Technical
- Relative Strength Index (RSI)
- XPOF 29.73
- ALT 69.04
- Support Level
- XPOF $5.58
- ALT $3.95
- Resistance Level
- XPOF $6.50
- ALT $4.23
- Average True Range (ATR)
- XPOF 0.39
- ALT 0.26
- MACD
- XPOF -0.03
- ALT 0.06
- Stochastic Oscillator
- XPOF 16.91
- ALT 92.16
About XPOF Xponential Fitness Inc.
Xponential Fitness Inc is a curator of boutique fitness brands. Its diversified portfolio of brands includes Club Pilates, a Pilates brand in the United States; CycleBar, an indoor cycling brand in the United States; StretchLab, a concept offering one-on-one and group stretching services; Row House, a high-energy, low-impact indoor rowing workout; AKT, a dance-based cardio workout combining toning, interval and circuit training; YogaSix a franchised yoga brand; Pure Barre, a total body workout that uses the ballet barre to perform small isometric movements; Stride, a treadmill-based cardio and strength training concept; Rumble, a boxing-inspired full-body workout; and BFT, a functional training and strength-based program. Its key revenue source is franchise income.
About ALT Altimmune Inc.
Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.